Anti-HIV Gel Flops, Trial Stops
557680
Women using a microbicide to prevent transmission of the AIDS virus become infected more often than those in a control group. In Sex Drive Daily.
432312
Over the next few months, officials in two US cities and several other countries will begin testing whether a popular AIDS drug can protect healthy people against HIV infection.
403859
TUESDAY, Oct. 5 (HealthDayNews) -- A trial for what appeared to be a promising new therapy for Parkinson's disease has been halted, although researchers haven't given up hope that the drug will one day prove useful.
378075
Sudden jumps of HIV levels in patients  taking drugs for the AIDS-causing infection are harmless blips  and do not mean the treatment against the virus is losing its  punch, a report said on Tuesday.
767331
Biopharma firm ends trials for a promising drug and offloads four commercial products.
542528
Sudden jumps of HIV levels in patients taking drugs for the AIDS-causing infection are harmless blips and do not mean the treatment against the virus is losing its punch, a report said on Tuesday.
465386
An experimental HIV drug from Merck &amp; Co. Inc. should be quickly approved for use by patients running out of treatment options, federal advisers recommended Wednesday.
36647
A cream designed to protect women from the AIDS virus did not prevent infection, but it was safe, raising hopes that it might be combined with drugs or other compounds to work better, researchers said on Monday.
50076
PRETORIA -- Ranbaxy Laboratories in India withdrew seven antiretroviral drugs for AIDS patients last month from the World Health Organization list of prequalified medicines. The company acknowledged that it did not complete proper lab tests to make sure its copycat drugs were equivalent with brand-name ones.
37552
The drug giant Merck suspends trials on an HIV vaccine that was regarded as one of the most promising.
693379
questions over testing of a key HIV/AIDS drug before a US-backed roll-out of the treatment across the continent. Ingelheim to hide adverse effects of nevirapine when used to try to prevent mother-to-child HIV transmission.
37345
Teva's lupus drug fails to meet its primary endpoint in its phase 2 trial.
745053
The strategy of fighting AIDS in Africa with questionable generic drugs made in developing countries now lies in shambles as an Indian company withdrew its medicines last week because it can&#39;t guarantee they are potent enough.
756760
Decode Genetics Inc. said on Thursday  it was halting its late-stage clinical trial program for an  experimental oral heart attack drug after a formulation problem  with the tablets cropped up.
186524
A government-sponsored trial of Pfizer  Inc.'s PFE.N blockbuster arthritis drug Celebrex was halted  after patients taking the medicine had more than twice as many  heart attacks as patients taking a placebo, the company said on  Friday.
454431
The drug company's experimental treatment for Alzheimer's  failed to prove effective in a big clinical trial. The stock  closed Tuesday at $45.85 on the New York Stock Exchange before  falling 10 percent in after-hours trading following release of  the trial results.
279208
A chemical specially designed to thwart how the AIDS virus invades during sex offers scientists a new lead in the long quest for a vaginal gel that women could apply to protect themselves when men don't use a condom.    The experimental drug isn't ready for human testing yet, but it provided potent protection to female monkeys exposed to large amounts of an AIDS virus, researchers reported Thursday in the journal Science...